Turner syndrome

Turner syndrome is a chromosomal condition affecting girls and women in which one intact X chromosome is present and the second sex chromosome is completely or partly missing or structurally altered. The chromosome difference may affect all cells or occur as mosaicism, with different chromosome complements in different cell populations. Short stature and reduced ovarian function are characteristic, but the combination and severity of features vary considerably. Most cases arise sporadically rather than being inherited. (medlineplus.gov)

The condition occurs in approximately 1 in 2,000–2,500 female live births, with estimates differing among sources and populations. Its medical significance extends beyond growth and puberty: congenital heart abnormalities, aortic disease, hearing impairment, and other associated conditions can affect health throughout life. Most affected individuals have intelligence within the normal range, although specific learning difficulties may occur. Diagnosis rests on chromosome analysis, while established care addresses individual manifestations through endocrine treatment and coordinated monitoring across childhood and adulthood. (medlineplus.gov)

Chromosomal forms and biological mechanisms

Turner syndrome encompasses several chromosomal configurations rather than a single genotype. Its defining chromosomal feature is one intact X chromosome together with complete or partial absence of the second sex chromosome, associated with characteristic clinical manifestations. In 45,X monosomy, cells contain 45 chromosomes instead of the usual 46, with only one X chromosome. The 2024 international clinical guidelines list 45,X in approximately 40–50% of affected individuals and 45,X/46,XX mosaicism in 15–25%. In this form of mosaicism, some cell lineages contain one X chromosome, whereas others contain two. Thus, “Turner syndrome” and “45,X” are not interchangeable terms. (firstpediatrics-uoa.com)

Structural variants retain a second X chromosome but lack or rearrange some of its genetic material. Deletions remove a segment of the short arm, Xp, or long arm, Xq. A ring X chromosome, written r(X), forms when chromosome ends join into a circular structure, often with loss of terminal material. An isochromosome of the long arm, i(Xq), has two copies of Xq rather than one short and one long arm, producing loss of Xp material alongside duplication of Xq. These variants may occur with a 45,X cell lineage. Not every X-chromosome deletion constitutes Turner syndrome: the 2024 guidelines exclude isolated deletions distal to Xq24 from its definition. (firstpediatrics-uoa.com)

Most cases arise sporadically rather than through transmission of a familial variant. Errors during reproductive-cell formation can produce an egg or sperm lacking a sex chromosome. One mechanism is nondisjunction, the failure of chromosomes to separate correctly during cell division; fertilization involving such a reproductive cell can produce a 45,X embryo. Alternatively, a chromosome-segregation error during early embryonic mitosis can establish genetically different cell lineages, producing mosaicism. These developmental events explain why a chromosomal condition can be genetic without usually being inherited. Rarely, a partial X-chromosome deletion is transmitted from one generation to the next. (medlineplus.gov)

The biological consequences depend partly on gene dosage, the number of functional copies of a gene. Although most genes on one X chromosome are normally silenced through X-chromosome inactivation in cells with two X chromosomes, some escape this process. Consequently, loss of a second X is not equivalent to loss of a wholly inactive chromosome: it reduces the dosage of genes normally expressed from both copies. Genes in the pseudoautosomal regions—corresponding regions shared by the X and Y chromosomes—are important examples. Their usual two-copy expression helps explain why having only one sex chromosome can affect development despite the presence of an intact X. (medlineplus.gov)

The best-established individual gene contribution involves SHOX, which encodes a transcription factor regulating skeletal development, particularly growth and maturation of the limb bones. People with typical XX or XY chromosome complements have two functional SHOX copies. Loss of one copy reduces production of its protein, an example of haploinsufficiency, and contributes to short stature and skeletal differences such as altered wrist and elbow alignment. SHOX loss does not, however, explain the entire syndrome. The specific genes and mechanisms responsible for most other manifestations, including cardiovascular, lymphatic, and ovarian abnormalities, remain incompletely established. (medlineplus.gov)

Frequency and prenatal natural history

Turner syndrome occurs in approximately 1 in 2,000–2,500 live-born females. Published estimates differ: MedlinePlus Genetics gives about 1 in 2,000 female newborns worldwide, whereas the US National Human Genome Research Institute gives about 1 in 2,500 female births. These figures correspond to approximately 40–50 affected newborns per 100,000 female live births. The denominator is female births, not all births, all pregnancies, or the total female population; the figures describe birth prevalence rather than the frequency of new diagnoses at every age. The two estimates are approximate descriptions of frequency, not evidence of a measured change over time. (medlineplus.gov)

Live-birth frequency substantially understates occurrence earlier in pregnancy, because affected pregnancies are disproportionately represented among miscarriages and stillbirths. These are distinct measures: prevalence among conceptions includes pregnancies lost before birth, whereas the proportion of miscarriages with an affected chromosome complement uses pregnancy losses as its denominator. Neither can be read directly from the live-birth estimate. A Danish registry study published in 1996 by Claus Højbjerg Gravholt and colleagues, covering 1970–1993, illustrates the difference between sampled populations: it reported 32 cases per 100,000 infant girls, compared with 176 Turner-associated chromosome complements per 100,000 female fetuses tested by amniocentesis. The latter group was a prenatally tested population, not a representative sample of all conceptions. (medlineplus.gov)

Studies of prenatal outcomes also distinguish spontaneous fetal death from termination of pregnancy. In a Welsh congenital-anomaly registry study covering January 1, 1998, through December 31, 2007, Narayan P. Iyer and colleagues identified 124 cases. The 45,X chromosome complement accounted for 74% of cases overall, but 92% of the fetal-loss group. Pregnancy was terminated in 66% of antenatally diagnosed cases. Consequently, the proportion of diagnosed pregnancies that did not result in live birth in this cohort cannot be interpreted as a spontaneous-loss rate. Prenatally detected cases and postnatally detected survivors also represented different distributions of chromosome complements and clinical findings. (pubmed.ncbi.nlm.nih.gov)

Prenatal ultrasonography may reveal a cystic hygroma, a fluid-filled swelling commonly involving the fetal head and neck. This finding can prompt chromosome analysis, but does not itself establish Turner syndrome. Increased nuchal thickness was the most frequently recorded antenatal ultrasound abnormality in the Welsh registry and was associated with 45,X and fetal loss. These observations help explain why cohorts assembled through abnormal prenatal scans may contain a greater proportion of severely affected fetuses than cohorts identified after birth. (medlineplus.gov)

Recognition may instead occur at birth, during childhood, in adolescence, or in adulthood. Swollen hands and feet or an unusually broad neck can lead to neonatal investigation; reduced growth commonly brings the condition to attention in childhood. In other individuals, absent or incomplete puberty becomes the first conspicuous indication. Adult diagnosis may follow investigation of absent or very light menstrual periods or difficulty becoming pregnant. Age at diagnosis therefore does not indicate when the chromosome difference arose: it records when its manifestations, or chromosome testing undertaken for another reason, brought it to clinical attention. (medlineplus.gov)

Growth and external physical features

Reduced linear growth is characteristic of Turner syndrome, but the difference from population averages changes with age. Birth length may be within the normal range, although the 2024 international clinical practice guidelines report an average deficit of approximately 1–2 cm compared with infants of similar gestational age and country of birth. Growth then falls progressively below population expectations: the downward crossing of height percentiles is particularly marked during the first two years, and a height deficit is generally established by age three. Thus, an apparently unremarkable length at birth does not exclude subsequent growth failure. (pmc.ncbi.nlm.nih.gov)

During childhood, slower growth increases the height difference from peers. The usual adolescent growth spurt is frequently minimal or absent, partly because ovarian insufficiency reduces estrogen production. Without growth-promoting treatment, reported average adult heights range from approximately 138 to 147 cm across countries, around 20 cm below population means in many settings. Reduced dosage of the SHOX gene, which participates in bone development, contributes to short stature and skeletal differences; the genetic mechanisms are discussed in the chromosomal section. Growth treatment is addressed separately from this description of the natural growth pattern. (pmc.ncbi.nlm.nih.gov)

External features vary considerably rather than forming a uniform appearance. A webbed neck, or pterygium colli, consists of lateral skin folds that give the neck a broad outline; a low posterior hairline may accompany it. The chest may be broad and relatively flat, with widely spaced nipples. Other possible findings include low-set ears, a high and narrow palate, a small or receding lower jaw, and drooping eyelids. These findings are not all present in every individual, and some children have few conspicuous external differences despite a marked reduction in growth. (genome.gov)

Congenital swelling of the hands and feet represents lymphedema, associated with abnormal development of vessels and valves in the lymphatic system. Impaired lymph drainage allows fluid to accumulate in tissues. The swelling often improves or resolves by about age two, although it can recur later. The 2024 guidelines report clinically apparent lymphedema in approximately 12%–27% of girls and women with Turner syndrome; prenatal lymphatic abnormalities may also contribute to neck webbing. Narrow, upward-curving nails are another recognized external finding. (pmc.ncbi.nlm.nih.gov)

Skeletal differences include short fingers and toes and an increased outward angle of the forearms at the elbows, termed cubitus valgus. Scoliosis, a lateral curvature of the spine, is another recognized association; the National Human Genome Research Institute describes it in approximately 10% of adolescent girls with the condition. These changes concern bone shape, alignment, and body proportions rather than height alone, and their presence and severity differ among individuals. (genome.gov)

Ovarian function, puberty, and fertility

Ovarian development begins during fetal life, but in Turner syndrome oocytes usually disappear prematurely, and much of the ovarian tissue may break down before birth. The resulting depletion of egg-containing follicles causes primary ovarian insufficiency, although its onset and severity vary. Reduced ovarian estrogen production limits breast development and other estrogen-dependent aspects of sexual maturation; many affected girls do not enter puberty without hormone replacement. This is principally an impairment of ovarian function rather than an absence of the reproductive tract. A minority retain functioning ovaries into young adulthood. (medlineplus.gov)

Spontaneous pubertal development does not necessarily indicate a sustained reproductive lifespan. The international guidelines published in 2024, following the 2023 Aarhus meeting, report that more than one-third of girls develop some spontaneous pubertal signs, but only about one in five experiences spontaneous menarche, the first menstrual period. Puberty may therefore begin and subsequently stall. Primary amenorrhea denotes the absence of an initial menstrual period, whereas secondary amenorrhea can follow an interval of spontaneous cycles as ovarian function declines. Retained function is more common in individuals with mosaicism involving a 46,XX cell line, but chromosome findings do not determine an individual’s reproductive capacity with certainty. (pmc.ncbi.nlm.nih.gov)

Ovarian insufficiency is distinct from uterine anatomy: the uterus and vagina are generally present, even when the ovaries are nonfunctional. Consequently, infertility usually reflects an inadequate supply of functioning oocytes rather than the absence of a uterus capable of carrying a pregnancy. (genome.gov) Natural conception is uncommon but documented, including in individuals reported to have a 45,X karyotype. A 2024 American Society for Reproductive Medicine review cited unassisted pregnancy rates of approximately 3%–8% in published studies. In vitro fertilization using donor oocytes can bypass the lack of usable eggs; pregnancy with an individual’s own oocytes is also possible in selected cases with residual ovarian function. Neither approach removes the maternal risks associated with Turner syndrome. (asrm.org)

Fertility-preservation approaches include freezing mature oocytes after ovarian stimulation and surgically collecting ovarian tissue for cryopreservation. Their applicability depends on remaining follicles, and evidence of subsequent reproductive success is limited. The first reported live birth using previously cryopreserved oocytes from an individual with Turner syndrome appeared in 2022. (asrm.org) The 2024 international guidelines described uncertain success rates for both approaches and restricted ovarian-tissue cryopreservation to research or clinical-ethics-approved settings. Detectable anti-Müllerian hormone, spontaneous puberty, and a 46,XX cell line are associated with a greater likelihood of finding residual follicles, but do not establish that preserved material will produce a live birth. (pmc.ncbi.nlm.nih.gov)

Pregnancy increases cardiovascular demands and can be complicated by hypertensive disorders, aortic dissection, or aortic rupture, regardless of the method of conception. Pre-existing aortic enlargement, bicuspid aortic valve, coarctation, and hypertension increase concern, although dissection has also occurred without recognized risk factors. The 2024 reproductive-medicine committee opinion estimated that death from pregnancy-associated aortic dissection or rupture may occur in as many as 1% of pregnancies, while emphasizing the limitations of evidence drawn largely from case reports and case series. Reproductive capacity and cardiovascular capacity to tolerate pregnancy are therefore separate clinical considerations. (asrm.org)

Cardiovascular abnormalities

Congenital heart disease is reported in approximately 23–50% of individuals with Turner syndrome, with estimates varying by the population studied and the imaging methods used. The characteristic lesions involve the left-sided outflow tract and aorta. A bicuspid aortic valve, reported in 14–40%, has two functional leaflets rather than the usual three; it may function normally or develop narrowing or regurgitation. Coarctation of the aorta, reported in 4–15%, is a localized narrowing, usually near the junction of the aortic arch and descending aorta. It obstructs blood flow and can produce higher blood pressure in the arms than in the legs. Both lesions may occur together. (pmc.ncbi.nlm.nih.gov) Other recognized abnormalities include an elongated transverse aortic arch, persistent left superior vena cava, and partial anomalous pulmonary venous return, in which some pulmonary veins connect to the systemic venous circulation rather than the left atrium. A 2025 expert statement by Katya de Groote and colleagues emphasized that these less conspicuous vascular abnormalities also contribute to the cardiovascular phenotype. (pubmed.ncbi.nlm.nih.gov)

Aortic enlargement is distinct from congenital valve disease or coarctation, although these conditions often coexist. Enlargement may involve the aortic root or ascending aorta and can progress over time. Because short stature is common in Turner syndrome, an absolute diameter considered unremarkable in a larger adult may represent substantial enlargement relative to body size. Assessment therefore uses measurements adjusted for height or body surface area, or age-appropriate Z-scores. The aortic size index, for example, divides aortic diameter in centimetres by body surface area in square metres. The 2022 American College of Cardiology/American Heart Association guideline identifies aortic dilation, bicuspid valve, coarctation, and hypertension as important risk factors for dissection. (pmc.ncbi.nlm.nih.gov)

Aortic dissection is an acute separation of the layers of the aortic wall, rather than simply an enlarged vessel. It can compromise arterial blood flow or lead to rupture. Most reported dissections in Turner syndrome involve the ascending aorta; the 2022 guideline gives a distribution of approximately 85% ascending and 15% descending dissections. Dissection can occur at smaller absolute aortic diameters than in the general population, making body-size-adjusted measurements particularly relevant. (pmc.ncbi.nlm.nih.gov) Hypertension is a separate, often acquired concern that increases the mechanical load on the aorta. The 2024 international guidelines report prevalence estimates as high as 20–40% in children and up to 60% in adults. Ambulatory blood-pressure monitoring can identify abnormalities not apparent during a single clinic measurement, including elevated nocturnal pressure. (pmc.ncbi.nlm.nih.gov)

Transthoracic echocardiography, a form of ultrasonography, and cardiovascular magnetic resonance imaging provide complementary information. Echocardiography depicts valve morphology, ventricular function, and blood-flow velocities, allowing assessment of valve obstruction, regurgitation, and the hemodynamic effects of coarctation. It is particularly practical in newborns and younger children because it generally requires no sedation. Its anatomical coverage may be limited by poor acoustic windows, especially in older children and adults. Cardiovascular magnetic resonance provides a wider view of the thoracic aorta, arch branches, and pulmonary venous connections without ionizing radiation. (onlinelibrary.wiley.com) The 2024 European Society of Cardiology guidelines describe baseline assessment with both modalities in newly diagnosed Turner syndrome; subsequent imaging frequency depends on aortic dimensions, age, and associated risk factors. (academic.oup.com)

Other associated medical conditions

Congenital renal malformations occur in approximately one third of people with Turner syndrome in the 2022 French national care protocol. Examples include horseshoe kidney, in which the kidneys are fused, abnormal rotation or position, absence of one kidney, and duplication of the collecting system. These are anatomical differences rather than evidence of acquired kidney failure. Most have little clinical consequence, although some predispose to urinary tract infection, obstruction with hydronephrosis, or hypertension. Renal ultrasonography identifies many of these abnormalities. (link.springer.com)

Middle-ear disease and hearing loss have partly distinct mechanisms. Underdevelopment and dysfunction of the Eustachian tubes favor recurrent otitis media, particularly between ages one and six. Fluid accumulation and middle-ear damage can produce conductive hearing loss, in which sound transmission is impaired. Sensorineural hearing loss, involving the inner ear or auditory pathway, can also begin in childhood and becomes more frequent with age; it is not simply a consequence of recurrent infection. Thus, congenital anatomical susceptibility and subsequently acquired hearing impairment should not be treated as the same finding. (link.springer.com)

Autoimmunity is another recognized association. The 2024 international guidelines identify Hashimoto thyroiditis as the most frequent autoimmune disease in Turner syndrome; thyroid dysfunction may lead to hypothyroidism. Celiac disease is also more frequent: evidence reviewed in those guidelines estimated its prevalence at approximately one in 22 affected individuals. Presentations include abdominal pain, diarrhea, anemia, and poor growth, but symptoms may be subtle. These associations represent increased susceptibility, not conditions present in every individual. (turnersyndromefoundation.org)

Obesity and diabetes mellitus are recognized complications, but neither is inevitable. (medlineplus.gov) Diabetes risk cannot be explained by excess weight alone: studies implicate both impaired pancreatic beta-cell function and insulin resistance, and diabetes may develop earlier than in the general population. (turnersyndromefoundation.org) Abnormal liver tests are also common. The French protocol reported abnormalities in approximately 30–50% by age 35. Associated pathology includes fatty liver and steatohepatitis, vascular changes with regenerative nodular hyperplasia, and less commonly biliary or autoimmune disease; an elevated enzyme result does not itself specify the underlying lesion. (link.springer.com)

Reduced bone mineral density and osteoporosis occur more often than in the general population. Estrogen deficiency contributes to impaired bone accrual, while celiac disease and other comorbidities can add risk. Interpretation requires attention to body size: dual-energy X-ray absorptiometry measures density per projected area, so short stature can make unadjusted values appear disproportionately low. A low measurement therefore requires distinction from established skeletal fragility or a history of fractures. (turnersyndromefoundation.org)

Cognition, learning, and psychosocial experience

Most people with Turner syndrome have overall intelligence within the normal range, although developmental and learning profiles vary considerably. The 2024 international clinical guidelines estimate that approximately 90% have overall intellectual abilities in the average range. Verbal reasoning is often a relative strength compared with visuospatial reasoning, so a single intelligence score may conceal substantial differences between abilities. Neither learning disability nor intellectual disability is an inevitable consequence of the condition, and individuals with the same chromosomal constitution can have different developmental profiles. (medlineplus.gov)

Documented learning difficulties include processing spatial relationships, remembering visual locations, and aspects of mathematics. These abilities are related but not interchangeable. A longitudinal study published in 2019 assessed girls with Turner syndrome and age-matched controls annually for four years: mathematical performance was associated with visual tracking, visual–motor coordination, and figure–ground processing—the ability to distinguish relevant visual information from its background. A separate study published in 2010 followed mathematical and executive skills from grades 1 to 6. Untimed mathematics achievement did not show the same difficulties as timed executive tasks and numerical-processing tests, illustrating how test demands can influence whether a learning difficulty becomes apparent. (pmc.ncbi.nlm.nih.gov)

Weaknesses in executive function may involve working memory, planning, organization, initiating tasks, and shifting between rules. They can overlap with visuospatial difficulties rather than representing wholly separate impairments. In a 2011 study, Jean-François Lepage and colleagues compared 36 prepubertal girls with Turner syndrome with 20 typically developing children; executive-function performance was closely associated with visuospatial ability in the Turner syndrome group but not in controls. These findings describe group-level relationships, not a uniform pattern in every child. Social-cognitive differences have also been documented, including difficulties interpreting social cues or understanding others’ perspectives, which are distinct from overall intellectual ability. (pubmed.ncbi.nlm.nih.gov)

Psychosocial research examines shyness, social anxiety, self-esteem, body image, and experiences associated with infertility or childlessness. These outcomes should not be treated as measures of intelligence. NICHD research has specifically investigated how ovarian insufficiency, sex-steroid effects, altered body image, and reproductive experiences relate to social functioning. In comparisons involving women with Turner syndrome, women with chromosomally typical premature ovarian failure, and women with normal ovarian function, both ovarian-failure groups reported greater shyness and social anxiety and lower self-esteem than the normal-ovarian-function group. This finding does not establish a single cause, but indicates that psychosocial experiences cannot be attributed solely to the Turner syndrome cognitive profile. (nichd.nih.gov)

Studies of quality of life distinguish overall well-being from difficulties in particular domains. A 2023 Malaysian cross-sectional study compared 24 women with Turner syndrome with 60 age-matched controls. Overall quality-of-life scores were similar, with no statistically significant differences in the physical, psychological, or environmental domains of the WHOQOL-BREF questionnaire. However, the Turner syndrome group had a lower median social-relationship score, 13.33 versus 16.00, and greater body-image-related interference with social functioning. The small, single-centre sample limits generalization, while its contrasting domain scores demonstrate that satisfactory overall quality of life can coexist with specific social or body-image concerns. (pmc.ncbi.nlm.nih.gov)

Diagnosis and interpretation of genetic tests

Clinical recognition can occur at several ages: congenital lymphedema of the hands and feet or a webbed neck may prompt testing in a newborn; unexplained short stature or slowing growth may lead to investigation during childhood; and delayed puberty, absent menstruation, or infertility may bring the condition to attention later. These findings raise suspicion rather than establish the diagnosis. Confirmation uses chromosome analysis, usually a karyotype prepared from peripheral-blood cells, to identify a missing or structurally altered X chromosome. The absence of conspicuous external features does not exclude the condition. (health.nih.gov)

Prenatal ultrasonography may reveal a cystic hygroma, increased nuchal translucency, or other abnormalities, but these findings are not specific to Turner syndrome; some affected fetuses have no detectable ultrasound abnormality. Cell-free DNA testing of maternal blood is likewise a screening test, not a fetal chromosome diagnosis. In a 2017 study using results from a large referral diagnostic laboratory, the positive predictive value for monosomy X was 26%: approximately one quarter of positive screens with diagnostic follow-up were confirmed. This figure describes that study population, not an invariant probability for every laboratory or pregnancy. (pmc.ncbi.nlm.nih.gov)

A central interpretive problem is that cell-free DNA screening samples maternal and placental DNA rather than fetal cells directly. An abnormal result can therefore reflect maternal sex-chromosome mosaicism or an abnormal cell population confined to the placenta. Diagnostic chromosome testing instead examines cells obtained through chorionic villus sampling or amniocentesis. Because chorionic villi are placental tissue, a mosaic result can require further clarification using amniotic-fluid cells. The 2025 Society for Maternal-Fetal Medicine guidance specifically identifies monosomy X as a condition in which confined placental mosaicism complicates interpretation and chorionic villus sampling may not be the preferred fetal diagnostic test. (pmc.ncbi.nlm.nih.gov)

Sampling also limits postnatal testing. The 2024 international guidelines specify counting at least 30 metaphase cells, which detects an approximately 10% mosaic cell population with 95% confidence. Smaller populations can escape detection, and blood may not represent other tissues. Additional metaphases or testing of buccal epithelium, skin, or urinary cells can clarify persistent clinical suspicion despite a 46,XX blood result. Fluorescence in situ hybridization (FISH) provides targeted chromosome-probe analysis; a 2004 study examined at least 200 interphase cells to investigate low-level mosaicism. (pmc.ncbi.nlm.nih.gov)

Detected Y-chromosome material has particular clinical significance because it is associated with gonadoblastoma in dysgenetic gonads, rather than merely defining another chromosome pattern. An unidentified marker chromosome may require FISH or molecular analysis to establish its origin. The 2024 guidelines support targeted molecular testing for Y material when a 45,X result accompanies virilization, but do not endorse such screening in every individual with 45,X. When Y material is identified, decisions concerning gonadectomy are individualized, balancing tumor risk against potential gonadal function and fertility. (pmc.ncbi.nlm.nih.gov)

Established treatment and lifelong care

Treatment addresses growth failure, ovarian hormone deficiency, and associated medical conditions; it does not correct the underlying chromosomal difference. Recombinant human growth hormone is administered during childhood to increase linear growth and adult height. Its effect is measurable but variable: a 2011 randomized, placebo-controlled clinical trial involving 149 girls aged 5.0–12.5 years at enrollment found an overall adult-height benefit of approximately 5.0 cm attributable to growth hormone. This represents a treatment-group average, not an expected gain for every child. Growth-promoting treatment and estrogen replacement have different purposes and may overlap during adolescence. (nichd.nih.gov)

Estrogen replacement supplies hormones that insufficiently functioning ovaries do not produce. It induces breast development and other secondary sexual characteristics, supports uterine maturation, and helps build and maintain bone mass. The 2024 international guidelines describe starting pubertal induction at approximately 11–12 years when ovarian insufficiency is established, with gradual escalation over 2–4 years to reproduce the tempo of puberty. Cyclic progesterone is subsequently added to protect the uterine lining from prolonged unopposed estrogen exposure. Following pubertal induction, adult hormone replacement generally continues until the usual age of menopause, approximately 50–55 years, when continued treatment is reassessed. This replacement is distinct from fertility treatment: producing pubertal development or withdrawal bleeding does not itself restore ovarian function. (nichd.nih.gov)

Lifelong care combines endocrinology and primary care with cardiology, gynecology, audiology, and other specialties according to individual findings. Surveillance covers the cardiovascular, hearing, thyroid, metabolic, liver, and skeletal conditions described in the organ-specific sections. The 2024 guidelines treat transfer from pediatric to adult services as a planned process rather than a single referral. Preparation includes understanding the diagnosis and medication regimen, developing appointment-management skills, transferring medical records, and identifying adult clinicians responsible for continuing surveillance. Completion of growth treatment does not mark the end of medical follow-up. (nichd.nih.gov)

Long-term outcomes are not uniform across physical health, reproductive development, and quality of life. Increased height, for example, is a different outcome from improved cardiovascular health or psychosocial functioning; each requires separate evaluation. NIH-supported research examines experiences involving infertility, body image, social anxiety, and sex-steroid treatment alongside physical outcomes. These studies distinguish the effects of the syndrome from the consequences of treatment and from the social circumstances in which care is received. (health.nih.gov)

Research on lifelong care also investigates which characteristics predict aortic dissection, how effectively medications limit aortic enlargement, and how cardiac function changes over time. Metabolic investigations address insulin resistance, while long-term treatment studies examine the effects of estrogen and growth hormone beyond their immediate developmental targets. NICHD identifies these as research objectives rather than established evidence that hormone treatment prevents later cardiovascular or metabolic disease. Longitudinal studies are particularly relevant because childhood growth responses and pubertal development can be measured years before many adult complications emerge. (health.nih.gov)

Historical recognition and research development

In 1930, the German pediatrician Otto Ullrich described an eight-year-old girl with several features subsequently associated with Turner syndrome: neck webbing, outward angulation of the elbows (cubitus valgus), congenital lymphatic swelling, prominent ears, a small lower jaw, drooping eyelids, and underdeveloped nails and nipples. His account emphasized a recognizable combination of congenital physical findings rather than a chromosomal disorder. In 1938, the American endocrinologist Henry Hubert Turner published A Syndrome of Infantilism, Congenital Webbed Neck, and Cubitus Valgus in Endocrinology. His seven patients, aged 15–23 years, combined reduced growth and absent or incomplete sexual maturation with neck webbing and cubitus valgus. The older ages made pubertal underdevelopment more evident than in Ullrich’s childhood description. These reports underlie the names Turner syndrome and Ullrich–Turner syndrome. (jamanetwork.com)

The decisive connection with cytogenetics came in 1959. On April 4, Charles Edmund Ford, K. W. Jones, Paul E. Polani, J. C. de Almeida, and J. H. Briggs published A Sex-Chromosome Anomaly in a Case of Gonadal Dysgenesis (Turner’s Syndrome) in The Lancet. They identified the chromosome constitution now designated 45,X: 45 chromosomes, including a single X chromosome, rather than the usual female complement of 46,XX. This established a cytogenetic basis for a condition previously recognized through its physical and developmental manifestations. The finding provided a means of connecting clinical phenotype with chromosome constitution; subsequent recognition of mosaicism and structural X-chromosome variants expanded the definition beyond that initial chromosome pattern. (pubmed.ncbi.nlm.nih.gov)

Multidisciplinary consensus guidance subsequently brought together research and clinical experience across the condition’s different organ systems. Carolyn A. Bondy and the Turner Syndrome Study Group published Care of Girls and Women with Turner Syndrome in the January 2007 issue of The Journal of Clinical Endocrinology & Metabolism, following online publication in October 2006. The guideline arose from a three-day meeting in Bethesda, Maryland, in April 2006, involving experts with relevant clinical and research experience. Its organization around care of both girls and women reflected the need to address childhood development alongside adult health, rather than treating short stature and pubertal development as the condition’s only clinical concerns. (pubmed.ncbi.nlm.nih.gov)

A further international consensus meeting took place in Cincinnati, Ohio, in July 2016, producing guidelines published in 2017 under the leadership of Claus H. Gravholt and colleagues. The next major revision followed exploratory meetings in Europe and the United States in 2021 and a consensus meeting in Aarhus, Denmark, in June 2023; the resulting guideline appeared in the European Journal of Endocrinology in June 2024. Eight working groups addressed diagnosis and genetics, growth, puberty and estrogen treatment, cardiovascular health, transition to adult services, fertility, lifelong surveillance of associated conditions, and neurocognition and mental well-being. Selected questions underwent formal evidence synthesis using the GRADE framework, while other recommendations incorporated expert consensus. The publication distinguished recommendation strength from evidence quality, explicitly identifying areas where clinical practice rested on limited research evidence. (pubmed.ncbi.nlm.nih.gov)

References

1. Clinical practice guidelines for the care of girls and women with Turner syndromefirstpediatrics-uoa.com
2. Turner syndrome: MedlinePlus Geneticsmedlineplus.gov
3. X chromosome: MedlinePlus Geneticsmedlineplus.gov
4. SHOX gene: MedlinePlus Geneticsmedlineplus.gov
5. About Turner Syndromegenome.gov
6. Turner syndrome: MedlinePlus Medical Encyclopediamedlineplus.gov
7. Prenatal and postnatal prevalence of Turner's syndrome: a registry studypubmed.ncbi.nlm.nih.gov
8. Outcome of fetuses with Turner syndrome: a 10-year congenital anomaly register based studypubmed.ncbi.nlm.nih.gov
9. Turner syndrome: MedlinePlus Medical Encyclopediamedlineplus.gov
10. Clinical practice guidelines for the care of girls and women with Turner syndrome: Proceedings from the 2023 Aarhus International Turner Syndrome Meetingpmc.ncbi.nlm.nih.gov
11. Clinical practice guidelines for the care of girls and women with Turner syndrometurnermadrid.es
12. Clinical practice guidelines for the care of girls and women with Turner syndrome: Proceedings from the 2023 Aarhus International Turner Syndrome Meetingpmc.ncbi.nlm.nih.gov
13. Management of Cardiovascular Health Issues in Turner Syndrome: Expert Insights and Expanded Recommendations From the 2024 Guideline Development Teampubmed.ncbi.nlm.nih.gov
14. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Diseasepmc.ncbi.nlm.nih.gov
15. Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol)link.springer.com
16. Clinical practice guidelines for the care of girls and women with Turner syndrometurnersyndromefoundation.org
17. On the relationship between mathematics and visuospatial processing in Turner syndromepmc.ncbi.nlm.nih.gov
18. Contribution of executive functions to visuospatial difficulties in prepubertal girls with Turner syndromepubmed.ncbi.nlm.nih.gov
19. 2009 Annual Report of the Division of Intramural Research, NICHD: Section on Epigenetics and Developmentannualreport.nichd.nih.gov
20. The quality of life and body image disturbances of Turner syndrome patients in Malaysia: a cross-sectional studypmc.ncbi.nlm.nih.gov
21. Turner Syndromehealth.nih.gov
22. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.pubmed.ncbi.nlm.nih.gov
23. Society for Maternal‐Fetal Medicine Consult Series #74: Cell‐free DNA screening for aneuploidies: Updated guidancepmc.ncbi.nlm.nih.gov
24. FISH analysis helps identify low-level mosaicism in Ullrich-Turner syndrome patientsnature.com
25. A Syndrome of Infantilism, Congenital Webbed Neck, and Cubitus Valgusturnersyndromesociety.org
26. Turner Syndrome — StatPearlsncbi.nlm.nih.gov
27. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome)pubmed.ncbi.nlm.nih.gov
28. 45,X — Chromosomal Variation in Manncbi.nlm.nih.gov
29. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Grouppubmed.ncbi.nlm.nih.gov
30. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meetingpubmed.ncbi.nlm.nih.gov
31. Clinical Practice Guidelines for the Care of Girls and Women With Turner Syndromedigitalcommons.library.tmc.edu
32. Clinical practice guidelines for the care of girls and women with Turner syndromepubmed.ncbi.nlm.nih.gov